Molina Healthcare, Inc. (MOH)

Molina Healthcare Stock Forecast

Stock Price Forecast

According to 18 analysts polled by S&P Global, Molina Healthcare stock has a consensus rating of "Hold" and an average price target of $182.88. The average 1-year stock price forecast is 1.60% lower than the current stock price, while the lowest is $129 (-30.59%) and the highest is $262 (+40.97%).

Price Target: $182.88 (-1.60%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$129	$182.88	$174.5	$262
Change	-30.59%	-1.60%	-6.11%	+40.97%

Analyst Ratings

The average analyst rating for Molina Healthcare stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	0	0	0	0	0	0
Buy	3	3	2	2	2	2
Hold	9	9	10	11	10	10
Sell	1	1	1	1	1	1
Strong Sell	0	0	0	0	0	0
Total	13	13	13	14	13	13

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
David Macdonald Truist Securities	Truist Securities	Hold Maintains $180 → $205	Hold	Maintains	$180 → $205	+10.30%	May 11, 2026
Sarah James Cantor Fitzgerald	Cantor Fitzgerald	Hold Maintains $144 → $209	Hold	Maintains	$144 → $209	+12.46%	May 11, 2026
Michael Ha Baird	Baird	Hold Maintains $124 → $163	Hold	Maintains	$124 → $163	-12.29%	May 11, 2026
Stephen Baxter Wells Fargo	Wells Fargo	Hold Maintains $141 → $159	Hold	Maintains	$141 → $159	-14.45%	Apr 27, 2026
David Macdonald Truist Securities	Truist Securities	Hold Maintains $145 → $180	Hold	Maintains	$145 → $180	-3.15%	Apr 27, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

44.70B

Increased by 2.62%

from 43.56B

Revenue Next Year

47.65B

Increased by 6.58%

from 44.70B

EPS This Year

5.25

Decreased by -41.11%

from 8.92

EPS Next Year

9.70

Increased by 84.71%

from 5.25

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	26.98B	31.10B	33.00B	39.16B	43.56B	44.70B	47.65B
Revenue Growth	46.85%	15.26%	6.12%	18.67%	11.23%	2.62%	6.58%
EPS	11.25	13.55	18.77	20.42	8.92	5.25	9.70
EPS Growth	0.18%	20.44%	38.52%	8.79%	-56.32%	-41.11%	84.71%
Forward PE	-	-	-	-	-	35.38	19.16
No. Analysts	-	-	-	-	-	23	22

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028	2029	2030	2031	2032	2033
High	47.9B	53.6B
Avg	44.7B	47.6B
Low	41.2B	41.5B

Revenue Growth

Revenue Growth	2026	2027	2028	2029	2030	2031	2032	2033
High	10.0%	19.9%
Avg	2.6%	6.6%
Low	-5.5%	-7.1%

EPS Forecast

EPS	2026	2027	2028	2029	2030	2031	2032	2033
High	5.88	14.18
Avg	5.25	9.70
Low	4.90	7.35

EPS Growth

EPS Growth	2026	2027	2028	2029	2030	2031	2032	2033
High	-34.1%	169.9%
Avg	-41.1%	84.7%
Low	-45.1%	40.0%

Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.